APAlex Paciorkowski

Alex Paciorkowski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alex Paciorkowski has a total of 134 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    BioVR: a platform for virtual reality assisted biological data integration and visualization

    by Jimmy F. Zhang, Alex R. Paciorkowski, Paul A. Craig, Feng Cui

    Functional characterization of single nucleotide variants (SNVs) involves two steps, the first step is to convert DNA to protein and the second step is to visualize protein sequences with their structures. As massively parallel sequencing has emerged as a leading technology in genomics, resulting in a significant increase in data volume, direct visualization of SNVs together with associated protein sequences/structures in a new user interface (UI) would be a more effective way to assess their potential effects on protein function. We have developed BioVR, an easy-to-use interactive, virtual reality (VR)-assisted platform for integrated visual analysis of DNA/RNA/protein sequences and protein structures using Unity3D and the C# programming language. It utilizes the cutting-edge Oculus Rift, and Leap Motion hand detection, resulting in intuitive navigation and exploration of various types of biological data. Using Gria2 and its associated gene product as an example, we present this proof-of-concept software to integrate protein and nucleic acid data. For any amino acid or nucleotide of interest in the Gria2 sequence, it can be quickly linked to its corresponding location on Gria2 protein structure and visualized within VR. Using innovative 3D techniques, we provide a VR-based platform for visualization of DNA/RNA sequences and protein structures in aggregate, which can be extended to view omics data.


  • Ode to the humble Southern blot in the era of exomes

    by Alex R. Paciorkowski

    Methods to perform the Southern blot, the separation of pieces of DNA by size and then identification with a molecular probe, were first published in 1975,1 before some of us in academic medicine had even entered preschool. It seems astonishing in this post–Human Genome Project era that the technique still has relevance in modern genetic diagnostics. Yet, even with the growing availability of exome sequencing, the Southern blot remains the method of choice to detect expansions in nucleotide repeats in the human genome. In this issue of Neurology® Clinical Practice , Wallace and Bird2 remind us that neurologists forget this at our peril.

  • Genetic Diagnostics for Neurologists

    by Laura Silveira-Moriyama, Alex R. Paciorkowski

    T, and it is now a routine part of the clinical care for a number of neurologic patients. In addition, phenotypic pleiotropy (mutations in the same gene causing very disparate phenotypes) and genetic heterogeneity (the same clinical phenotype resulting from mutations in different genes) are now known to exist in a number of conditions, adding an additional layer of complexity for genetic testing in these disorders. SUMMARY Although the growing complexity of technical knowledge in the ordering and interpretation of genetic tests makes it necessary for neurologists to consult medical geneticists, limitations in the availability of such professionals often means neurologists will be on the front line dealing with suspected or confirmed neurogenetic conditions. The growing availability of broad genetic testing through chromosomal microarray and next-generation sequencing and the expanded phenotypic spectrum of many conditions has implications for genetic counseling and medical management. This article discusses the various forms of genetic variability and how to test for each of them. It also provides an update on the most common forms of neurologic presentations of genetic disease and a review of testing strategies....


  • Expanding the neurodevelopmental phenotype ofPURAsyndrome

    by Bo Hoon Lee, Margot R. F. Reijnders, Oluwatobi Abubakare, Emily Tuttle, Brynn Lape, Kelly Q. Minks, Christopher Stodgell, Loisa Bennetto, Jennifer Kwon, Chin‐To Fong, et al.

    PURAsyndrome is a recently described developmental encephalopathy presenting with neonatal hypotonia, feeding difficulties, global developmental delay, severe intellectual disability, and frequent apnea and epilepsy. We describe 18 new individuals with heterozygous sequence variations inPURA. A neuromotor disorder starting with neonatal hyptonia, but ultimately allowing delayed progression to walking, was present in nearly all individuals. Congenital apnea was present in 56% during infancy, but all cases in this cohort resolved during the first year of life. Feeding difficulties were frequently reported, with gastrostomy tube placement required in 28%. Epilepsy was present in 50% of the subjects, including infantile spasms and Lennox–Gastaut syndrome. Skeletal complications were found in 39%. Disorders of gastrointestinal motility and nystagmus were also recurrent features. Autism was diagnosed in one individual, potentially expanding the neurodevelopmental phenotype associated with this syndrome. However, we did not find additionalPURAsequence variations in a cohort of 120 subjects with autism. We also present the first neuropathologic studies ofPURAsyndrome, and describe chronic inflammatory changes around the arterioles within the deep white matter. We did not find significant correlations between mutational class and severity, nor between location of the sequence variation in PUR repeat domains. Further studies are required in larger cohorts of subjects withPURAsyndrome to clarify these genotype–phenotype associations.


  • Open Access

    Congenital Zika syndrome: an epidemic of neurologic disability

    by Alex R. Paciorkowski

    The paper by van der Linden et al., “Discordant clinical outcomes of congenital Zika virus infection in twin pregnancies”1 provides additional information in a story that has placed Zika firmly in the company of other infections such as cytomegalovirus and toxoplasmosis that can cause birth defects in the central nervous system. Unlike these other congenital infections, however, Zika virus regularly causes a particularly severe brain phenotype, rarely seen even by specialists in brain malformations. While microcephaly, central nervous system calcifications, and abnormal gyral patterning can be observed as sequelae of other congenital infections, in the case of Zika these aspects have been notably pronounced and severe2.


  • Open Access

    India Allele Finder: a web-based annotation tool for identifying common alleles in next-generation sequencing data of Indian origin

    by Jimmy F. Zhang, Francis James, Anju Shukla, Katta M. Girisha, Alex R. Paciorkowski

    We built India Allele Finder, an online searchable database and command line tool, that gives researchers access to variant frequencies of Indian Telugu individuals, using publicly available fastq data from the 1000 Genomes Project. Access to appropriate population-based genomic variant annotation can accelerate the interpretation of genomic sequencing data. In particular, exome analysis of individuals of Indian descent will identify population variants not reflected in European exomes, complicating genomic analysis for such individuals. India Allele Finder offers improved ease-of-use to investigators seeking to identify and annotate sequencing data from Indian populations. We describe the use of India Allele Finder to identify common population variants in a disease quartet whole exome dataset, reducing the number of candidate single nucleotide variants from 84 to 7. India Allele Finder is freely available to investigators to annotate genomic sequencing data from Indian populations. Use of India Allele Finder allows efficient identification of population variants in genomic sequencing data, and is an example of a population-specific annotation tool that simplifies analysis and encourages international collaboration in genomics research.


  • PLXNA1 developmental encephalopathy with syndromic features: A case report and review of the literature

    by Kaylee Park, Laurie E. Seltzer, Emily Tuttle, Ghayda M. Mirzaa, Alex R. Paciorkowski

    Developmental encephalopathies constitute a broad and genetically heterogeneous spectrum of disorders associated with global developmental delay, intellectual disability, frequent epilepsy, and other neurofunctional abnormalities. Here, we report a male presenting with infantile onset epilepsy and syndromic features resembling Dubowitz syndrome identified to have a de novo PLXNA1 variant by whole exome sequencing. This constitutes the second report of PLXNA1 sequence variation associated with early onset epilepsy, and the first to expand on the clinical features of this emerging disorder. This reports suggests that nonsynonymous de novo sequence variations in PLXNA1 are associated with a novel human phenotype characterized by intractable early onset epilepsy, intellectual disability, and syndromic features.


  • Neurogenetics in the Genome Era

    by Kelly McMahon, Alex R. Paciorkowski, Lauren C. Walters-Sen, Jeff M. Milunsky, Alexander Bassuk, Benjamin Darbro, Jullianne Diaz, William B. Dobyns, Andrea Gropman


  • Epilepsy-causing sequence variations in SIK1 disrupt synaptic activity response gene expression and affect neuronal morphology

    by Christoph Pröschel, Jeanne N Hansen, Adil Ali, Emily Tuttle, Michelle Lacagnina, Georgia Buscaglia, Marc W Halterman, Alex R Paciorkowski

    The European Journal of Human Genetics is the official Journal of the European Society of Human Genetics, publishing high-quality, original research papers, short reports, News and Commentary articles and reviews in the rapidly expanding field of human genetics and genomics.